|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
|
|---|---|---|---|
| Operating activities | |||
| Net income (loss) | |||
| Non-cash item adjustments: | |||
| Non-cash operating lease expense | |||
| Depreciation of right-of-use assets – finance lease | |||
| Depreciation of property, plant and equipment | |||
| Consulting service fees to four independent consultants under Stock Incentive Plan | |||
| Consulting services settled by issuance of ordinary shares | |||
| Deferred tax expenses (recovery) | |||
| Loss (gain) on termination of right-of-use assets – finance lease | |||
| (Reversal of) Allowance for expected credit loss | |||
| Change in working capital items: | |||
| Change in accounts receivable – third parties | |||
| Change in accounts receivable – related parties | |||
| Change in retention receivable | |||
| Change in prepayment, deposits and other receivables | |||
| Change in accounts payable, accruals and other current liabilities | |||
| Change in accounts payable – related parties | |||
| Change in contract liabilities | |||
| Change in income taxes payable | |||
| Change in due to related parties | |||
| Change in lease liabilities – Operating lease | |||
| Cash provided by (used in) operating activities | |||
| Investing activity | |||
| Payment for potential investment in Wangmao | |||
| Proceeds from termination of finance lease | |||
| Cash provided by (used in) investing activity | |||
| Financing activities | |||
| Repayments to a related party | |||
| New borrowings from a related party | |||
| Repayment of bank loans | |||
| Proceeds from disposal ROU-finance lease | |||
| Initial payment of finance lease | |||
| Initial payment of finance lease – related parties | |||
| Principal payment of finance lease liabilities | |||
| Principal payment of finance lease liabilities – related parties | |||
| Payment of offering costs | |||
| Proceeds from issuance of common stock, net of issuance costs | |||
| Net proceeds from issuance of ordinary shares to 16 investors related to PIPE transaction in 2025-11 | |||
| Proceeds from issuance of shares to 4 individuals related to SPA in 2026-02 | |||
| Cash (used in) provided by financing activities | |||
| Net increase (decrease) in cash and cash equivalents | |||
| Cash and cash equivalents as of beginning of the year | |||
| Effect of exchange rate changes on cash and cash equivalents | |||
| Cash and cash equivalents as of the end of the year | |||
| Supplementary Cash Flows Information | |||
| Cash paid for interest | |||
| Cash paid for income tax | |||
| Ordinary shares issued for settlement of consulting fees related to four independent consultants | |||
| Consulting fees paid by issuance of ordinary shares | |||
| Accruals for offering cost | |||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||
| Right-of-use assets obtained in exchange for new finance lease liabilities |
Loading...